We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Eli Lilly
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
586 19 0 LLY
Emcee:  Frank Stein Type:  Unmoderated
Eli Lilly spent a lot of money on PCS. They
sold the highly profitable Guidant to do it.
This hasn't paid off for them. Could this be
the downfall of CEO Randall Tobias.....

Any Comments?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
586Eli Lilly CEO: Speed and industry cooperation are aiding coronavirus treatment Moonray-Wednesday
585Lilly, Amgen Ink Manufacturing Deal for Coronavirus Antibodies Eli Lilly & Moonray-last Saturday
584COVID-19 treatment linked to B.C. biotech shows signs of reducing hospitalizatiMoonray-last Saturday
583Eli Lilly Reports Success With COVID-19 Neutralizing Antibody Treatment GetMoonray-September 16
582Lilly, Incyte Announce Initial Data From Adaptive COVID-19 Treatment Trial - QuMoonray-September 14
581Chart looks primed for a run. There is bullish crossover in MACD and Stochastic Alejandroo Green-September 8
580The world desperately needs coronavirus treatments, even if we get a vaccine. TMoonray-August 20
579Eli Lilly Expands Pact With China Partner, Bringing Lymphoma Drug To U.S. o~~~ Moonray-August 18
578U.S. begins trials of Eli Lilly’s antibody drug Berkeley Lovelace Jr The NatiMoonray2August 5
577More: Eli Lilly launches late-stage antibody treatment trial to be tested in USMoonray-August 3
576Eli Lilly starts late-stage study of coronavirus drug in nursing homes PUBLISHGlenn Petersen2August 3
575LLY 153.00 -8.75 (-5.41%) As of 11:04AM EDT. Eli Lilly's stock rallies aMoonray-July 30
574"The results from this study are promising to people around the world who Moonray-July 17
573The key takeaway It is worth noting that Eli Lilly's lineup goes beyond Moonray-July 8
572All Time High on LLY today at $168.92. o~~~ OMoonray-July 6
571LLY today, up with the DOW, 162.86 +5.83 (3.71%) Point & Figure chart says tMoonray-June 25
570Lilly's Covid-19 drug could be ready for use as soon as Sept, says chief scMoonray-June 23
569Point & Figure has a new bullish objective ($219) with buy point $148-$152. Moonray-June 19
568LLY should be bought at the two EMA and gap at $150: [graphic] o~~~ OMoonray-June 19
567Recap of the Week’s Most Important Stories: Lilly Begins Phase III Study on OluMoonray-June 19
566Lilly commences Phase III trial of baricitinib to treat Covid-19 Eli Lilly has Moonray-June 18
565Eli Lilly Up Over 12%, On Pace for Largest Percent Increase Since October 2008 Moonray1June 16
564FDA Approves Lilly's New Rapid-acting Insulin Lyumjev FDA approves Lyumjev™Moonray-June 16
563Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug TMoonray1June 16
562Eli Lilly Is a Big Pharma Play With Big Potential o~~~ OMoonray-June 15
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):